Cancer Institute of New Jersey (CINJ), Division of Molecular Oncology

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Division of Molecular Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Shridar Ganesan

    Shridar Ganesan

    Person

    19902024

    Projects

    Impact of mutation burden on cancer growth and the immune landscape

    Ganesan, S., Lattime, E. & White, E.

    National Institutes of Health

    12/1/19 → 11/30/24

    Project: Research project

    • ENDOGENOUS RETROVIRUS EXPRESSION, CHROMATIN ABNORMALITIES, AND RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN CLEAR CELL RENAL CELL CANCER

    Ganesan, S.

    Congressionally Directed Medical Research Programs (CDMRP)

    9/30/19 → 9/29/21

    Project: Research project

    • Computerized histologic image predictor of cancer outcome

    Ganesan, S., Madabhushi, A. & Feldman, M.

    National Institutes of Health

    7/1/16 → 6/30/21

    Project: Research project

    • Research Output

    The Pan-Cancer Landscape of Coamplification of the Tyrosine Kinases KIT, KDR, and PDGFRA

    Disel, U., Madison, R., Abhishek, K., Chung, J. H., Trabucco, S. E., Matos, A. O., Frampton, G. M., Albacker, L. A., Reddy, V., Karadurmus, N., Benson, A., Webster, J., Paydas, S., Cabanillas, R., Nangia, C., Ozturk, M. A., Millis, S. Z., Pal, S. K., Wilky, B., Sokol, E. S. & 14 others, Gay, L. M., Soman, S., Ganesan, S., Janeway, K., Stephens, P. J., Zhu, V. W., Ou, S. H. I., Lovly, C. M., Gounder, M., Schrock, A. B., Ross, J. S., Miller, V. A., Klempner, S. J. & Ali, S. M., Jan 1 2020, In : Oncologist. 25, 1, p. e39-e47

    Research output: Contribution to journal › Article

    Open Access

    • A Novel Acquired Exon 20 EGFR M766Q Mutation in Lung Adenocarcinoma Mediates Osimertinib Resistance but is Sensitive to Neratinib and Poziotinib

    Castellano, G. M., Aisner, J., Burley, S. K., Vallat, B., Yu, H. A., Pine, S. R. & Ganesan, S., Nov 2019, In : Journal of Thoracic Oncology. 14, 11, p. 1982-1988 7 p.

    Research output: Contribution to journal › Article

    • 3 Scopus citations